-
Eli Lilly & Co. said Friday it would stop promoting a relatively new cancer drug after a follow-up study found it failed to significantly prolong the lives of patients. Analysts said regulators in the U.S. and Europe could withdraw their approvals of …
-
With EIN Presswire press release distribution services you will reach decision makers and journalists plus get valuable SEO benefits.
-
… advanced or metastatic soft tissue sarcoma (STS), did not confirm … anti-tumor activity against selected sarcoma cell lines and disrupted … clinical trials for LARTRUVO in sarcoma can be found at … adult patients with soft tissue sarcoma (STS) with a histologic …
-
… trial of a treatment for sarcoma did not meet the primary … patients with advanced soft tissue sarcoma in this study," said … advanced or metastatic soft tissue sarcoma or STS, did not confirm …
-
… trial of a treatment for sarcoma failed to meet its main … advanced or metastatic soft tissue sarcoma (STS) did not meet its … patients with advanced soft tissue sarcoma in this study," said …
